Routine Immunization Schedules
A different schedule may be needed for high-risk individuals, individuals NOT previously immunized or if one or more doses of a vaccine are missed. Talk to your health care provider for more information about immunization.
On this page:
- Immunization Schedule for Infants and Pre-School Children
- School Immunization Schedule
- Immunization Schedule for Adults
Click here to view a printable version
For a list of vaccines offered free-of-charge, click here
Recommended Immunization Schedule for Infants and Pre-School Children
Effective June 2024
NOTE: (Click on links to open Fact Sheets)
| Vaccine | Age of Child | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2 months |
4 months |
6 months |
12 months |
18 months |
4-6 years |
||||
| Diphtheria, Tetanus, Pertussis, Polio, Haemophilus influenzae type b (DTaP-IPV-Hib) | ♦ | ♦ | ♦ | ♦ | |||||
| Pneumococcal Conjugate 15 valent (Pneu-C-15) ^ | ♦ | ♦ | ♦ | ||||||
| Rotavirus | ♦ | ♦ | |||||||
| Measles, Mumps, Rubella, Varicella (MMRV) | ♦ | ♦ | |||||||
| Meningococcal Conjugate Quadrivalent (Men-C-ACYW)* |
♦ | ||||||||
| Tetanus, Diphtheria, Pertussis, Polio (Tdap-IPV) | ♦ | ||||||||
| Influenza (Flu) | All Manitobans 6 months of age and older are eligible for influenza vaccine each year. Click here for current information on the seasonal influenza vaccine. |
||||||||
♦ = A single vaccine dose given.
^ = Children with high-risk medical conditions and those living in First Nations communities should be immunized with Pneumococcal Conjugate 20 valent (Pneu-C-20) at 2, 4, 6 and 18 months. Please see Eligibility Criteria for high risk criteria.
* As of March 1, 2024, a meningococcal vaccine that protects against four strains is offered as part of the Immunization Schedule for Infants and Pre-School Children.
- Nimenrix® is the recommended product if the pneumococcal vaccine is also being administered as Nimenrix® does not decrease the immune response to the pneumococcal vaccine (i.e., Prevnar® 13). Nimenrix® is given as a single dose to children 12 months and older.
- For children 12 to 23 months of age, Menactra® has a 2-dose schedule with the second dose given at least 3 months apart.
- For children 24 months and older, Menactra® can be given as a single dose.
- Those with certain high-risk medical conditions may require additional doses. Refer to the Manitoba Health, Seniors and Long-Term Care eligibility criteria and the Canadian Immunization Guide for dose requirements and intervals.
Recommended School Immunization Schedule
NOTE: (Click on links to open Fact Sheets)
| Vaccine | Age of Child | |
|---|---|---|
| Grade 6 | Grade 8 or 9 | |
| Meningococcal Conjugate Quadrivalant (Men-C-ACYW) | ♦ | |
| Hepatitis B (HB) | ♦ ♦ | |
| Human Papillomavirus (HPV) | ♦ ♦ |
|
| Tetanus, Diphtheria, Pertussis (Tdap) | ♦ | |
| Influenza (Flu) | All Manitobans 6 months of age and older are eligible for influenza vaccine each year. Click here for current information on the seasonal influenza vaccine. |
|
♦ = A single vaccine dose given.
* Starting September 2019, a meningococcal vaccine that will protect against four strains will be offered as part of Manitoba's School-Based Immunization Program in grade 6.
Recommended Immunization Schedule for Adults
NOTE: (Click on links to open Fact Sheets)
| Vaccine | Age of Person | ||
|---|---|---|---|
| All adults |
65 years |
||
| Tetanus, Diphtheria, Pertussis (Tdap) * | ♦ | ||
| Tetanus, Diphtheria (Td) | ♦ Every 10 years |
||
| Pneumococcal Conjugate (Pneu-C-20) ** | ♦ Lifetime dose |
||
| Influenza (Flu) | All Manitobans 6 months of age and older are eligible for influenza vaccine each year. Individuals aged 65 years and older are eligible for the high-dose influenza vaccine. Click here for current information on the seasonal influenza vaccine. |
||
♦ = A single vaccine dose given.
* = Tdap vaccine is available for adults who are due for a tetanus booster and have not previously received a pertussis-containing vaccine in adulthood and pregnant women in every pregnancy optimally between 27 and 32 weeks gestation.
** = Pneu-C-20 is available for adults 65 years and older who have not yet received Pneu-P-23 since turning age 65. If they had received a dose of Pneu-P-23 before turning 65, Pneu-C-20 can be administered 5 years after that dose. (Note: There is currently no recommendation to administer a dose of Pneu-C-20 if someone has already received a dose of Pneu-C-20 before turning 65.)
